Paying user area
Try for free
Abbott Laboratories pages available for free this week:
- Income Statement
- Analysis of Short-term (Operating) Activity Ratios
- Analysis of Reportable Segments
- Present Value of Free Cash Flow to Equity (FCFE)
- Selected Financial Data since 2005
- Return on Equity (ROE) since 2005
- Return on Assets (ROA) since 2005
- Price to Book Value (P/BV) since 2005
- Analysis of Revenues
- Analysis of Debt
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Abbott Laboratories for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Adjusted Financial Ratios (Summary)
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
- Total Asset Turnover
- The reported total asset turnover exhibited an upward trend from 0.48 in 2020 to 0.59 in 2022, indicating improved efficiency in using assets to generate sales. However, it declined thereafter to 0.52 in 2024. The adjusted figures largely mirrored this pattern but showed a continued increase towards 0.57 in 2024, suggesting some operational adjustments contributed to better asset utilization in the latter year.
- Current Ratio
- The current ratio, representing short-term liquidity, increased from 1.72 in 2020 to a peak of approximately 1.85 in 2021, indicating enhanced capacity to cover short-term liabilities. This was followed by a decrease to about 1.63-1.66 in 2022 and 2023, but a slight recovery to roughly 1.67 in 2024. Adjusted current ratios showed a similar trend with consistently slightly higher values, reflecting reliable liquidity maintenance.
- Debt to Equity Ratio
- There was a consistent decline in the reported debt to equity ratio over the period, from 0.57 in 2020 to 0.30 in 2024, indicating a progressive reduction in reliance on debt financing relative to shareholders' equity. The adjusted metric also decreased, though less sharply, from 0.59 to 0.38, underscoring a conservative deleveraging approach.
- Debt to Capital Ratio
- The reported debt to capital ratio followed a steady downward trend from 0.36 in 2020 to 0.23 in 2024, confirming the reduction in debt proportion within the company’s capital structure. Adjusted figures showed a similar trajectory but remained at slightly higher values near 0.28 in the final year, indicating some variance in debt classification or adjustments.
- Financial Leverage
- Both reported and adjusted financial leverage declined progressively from above 2.1 in 2020 to below 1.9 reported and about 1.82 adjusted in 2024. This reduction reflects a less leveraged capital structure, consistent with the declining debt ratios, and implies potentially lower financial risk.
- Net Profit Margin
- The reported net profit margin rose significantly from around 13% in 2020 to nearly 32% in 2024, suggesting a notable increase in profitability or extraordinary gains during the latest period. However, the adjusted margin peaked in 2021 at approximately 16.65% and then declined to about 12.7% in 2024, indicating that the exceptional rise in reported margin might be influenced by non-recurring factors.
- Return on Equity (ROE)
- The reported ROE increased from 13.7% in 2020 to 28.1% in 2024, with a peak around 19.75% in 2021, connoting an improvement in shareholder value creation. Conversely, the adjusted ROE showed a decline to 13.3% in 2024 from around 19.6% in 2021, reflecting a more conservative assessment excluding one-time effects.
- Return on Assets (ROA)
- The reported ROA rose from 6.2% in 2020 to 16.5% in 2024, peaking in the final year, implying improved efficiency in asset utilization for generating profits. The adjusted ROA remained relatively stable, rising modestly from 5.49% to 7.3% over the period, indicating consistent operational performance when adjustments for extraordinary items are considered.
Abbott Laboratories, Financial Ratios: Reported vs. Adjusted
Adjusted Total Asset Turnover
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
1 2024 Calculation
Total asset turnover = Net sales ÷ Total assets
= ÷ =
2 Adjusted total assets. See details »
3 2024 Calculation
Adjusted total asset turnover = Net sales ÷ Adjusted total assets
= ÷ =
The analysis of the financial data reveals several notable trends and changes over the five-year period.
- Net Sales
- Net sales increased significantly from US$ 34,608 million in 2020 to a peak of US$ 43,653 million in 2022. However, there was a decline in 2023 to US$ 40,109 million, followed by a moderate recovery to US$ 41,950 million in 2024. Overall, the sales trend shows initial strong growth with some volatility in recent years.
- Total Assets
- Total assets rose steadily from US$ 72,548 million in 2020 to US$ 75,196 million in 2021, then experienced a slight decline over the next two years to US$ 73,214 million in 2023. A pronounced increase occurred again in 2024, reaching US$ 81,414 million. This suggests that asset growth was somewhat inconsistent but ended with substantial expansion in the latest year.
- Reported Total Asset Turnover
- The reported total asset turnover ratio improved from 0.48 in 2020 to a high of 0.59 in 2022, indicating more effective use of assets to generate sales during that period. However, this ratio decreased to 0.55 in 2023 and further declined to 0.52 in 2024, reflecting a reduction in asset utilization efficiency relative to the peak year.
- Adjusted Total Assets
- Adjusted total assets followed a similar trajectory to reported total assets, increasing from US$ 71,673 million in 2020 to US$ 74,303 million in 2021 and then gently declining to US$ 72,473 million in 2023. In 2024, adjusted assets rose modestly to US$ 73,038 million, showing more stability compared to reported total assets.
- Adjusted Total Asset Turnover
- Adjusted total asset turnover was relatively stable, with an increase from 0.48 in 2020 to 0.59 in 2022. It then declined to 0.55 in 2023 but recovered to 0.57 in 2024. This pattern suggests that when adjusting for asset measures, the efficiency in asset use rebounded somewhat after the decline observed in 2023.
In summary, the data depict a period of generally increasing sales and asset bases with fluctuations in asset turnover ratios. The peak effectiveness in asset utilization occurred in 2022, with some declines thereafter but partial recovery in adjusted measures by 2024. The overall financial position indicates resilience with periods of both growth and modest contractions in operational efficiency.
Adjusted Current Ratio
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
1 2024 Calculation
Current ratio = Current assets ÷ Current liabilities
= ÷ =
2 Adjusted current assets. See details »
3 2024 Calculation
Adjusted current ratio = Adjusted current assets ÷ Current liabilities
= ÷ =
The financial data indicates varying trends in both current assets and liabilities over the five-year period from 2020 to 2024. Current assets increased from 20,441 million US dollars at the end of 2020 to a peak of 25,224 million in 2022, before declining to 22,670 million in 2023 and then moderately rebounding to 23,656 million in 2024. This fluctuation suggests some volatility in the company's short-term resources available for meeting obligations.
Current liabilities followed an upward trajectory from 11,907 million in 2020 to a high of 15,489 million in 2022. However, liabilities decreased significantly in 2023 to 13,841 million and showed a slight increase to 14,157 million by the end of 2024. This pattern indicates a peak liability burden in 2022 followed by a reduction, which may reflect changes in payable schedules or short-term debt management.
The reported current ratio, a liquidity measure that compares current assets to current liabilities, initially shows improvement from 1.72 in 2020 to 1.85 in 2021, signaling strengthened liquidity. This ratio then declines to 1.63 in 2022, remaining fairly stable around 1.64 in 2023 and slightly improving to 1.67 in 2024. These figures suggest a reduction in liquidity relative to liabilities after 2021, though the company maintains a ratio above 1, reflecting ongoing ability to cover short-term obligations.
Adjusted current assets—presumably reflecting certain reclassifications or adjustments—mirror the pattern seen in reported current assets, increasing from 20,729 million in 2020 to 25,486 million in 2022, followed by decreases in 2023 and a partial recovery by 2024. This consistent trend strengthens the observations regarding asset volatility.
The adjusted current ratio moves closely with the reported current ratio, rising from 1.74 in 2020 to 1.87 in 2021, dropping to 1.65 in 2022, remaining steady at 1.66 in 2023, and nudging higher to 1.69 in 2024. The similarity between reported and adjusted ratios suggests that adjustments do not materially alter the liquidity view, validating the overall assessment of a moderate decline after 2021 with a partial recovery thereafter.
- Summary of Key Trends:
- - Current assets and adjusted current assets peaked in 2022 before declining and then partially recovering in 2024.
- - Current liabilities increased substantially until 2022, then declined in 2023 with a slight increase in 2024.
- - Both reported and adjusted current ratios improved in 2021, declined notably in 2022, and showed modest recovery by 2024, but remained above 1.6.
- - While liquidity remained adequate throughout, the data highlights fluctuations in asset and liability levels impacting short-term financial stability.
Adjusted Debt to Equity
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
1 2024 Calculation
Debt to equity = Total debt ÷ Total Abbott shareholders’ investment
= ÷ =
2 Adjusted total debt. See details »
3 Adjusted total shareholders’ investment. See details »
4 2024 Calculation
Adjusted debt to equity = Adjusted total debt ÷ Adjusted total shareholders’ investment
= ÷ =
The financial data exhibits a consistent downward trend in the company's debt levels over the five-year period from 2020 to 2024. Both total debt and adjusted total debt decrease steadily each year, indicating a deliberate effort to reduce liabilities. Total debt diminishes from 18,747 million US dollars in 2020 to 14,125 million US dollars in 2024, while adjusted total debt declines from 19,890 million US dollars to 15,275 million US dollars in the same timeframe.
Conversely, shareholders’ investment shows an upward trajectory. The reported total Abbott shareholders’ investment rises from 32,784 million US dollars in 2020 to 47,664 million US dollars in 2024. Similarly, adjusted total shareholders’ investment grows gradually from 33,604 million US dollars to 40,046 million US dollars during this period. This increase in equity suggests strengthening financial stability and potentially enhanced investor confidence.
Financial leverage metrics reflect these shifts as well. The reported debt-to-equity ratio decreases consistently from 0.57 in 2020 to 0.30 in 2024. This reduction highlights a improving balance between debt and equity financing, with equity increasingly dominating the capital structure. Adjusted debt-to-equity ratios follow the same pattern, dropping from 0.59 to 0.38 over the five years, reinforcing the overall trend toward reduced financial risk through lower leverage.
In summary, the data illustrates a strategic movement toward lower indebtedness combined with sustained growth in shareholders’ equity, resulting in markedly reduced leverage ratios. These trends point to enhanced financial health and potentially improved capacity to withstand economic fluctuations or invest in future growth initiatives.
Adjusted Debt to Capital
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
1 2024 Calculation
Debt to capital = Total debt ÷ Total capital
= ÷ =
2 Adjusted total debt. See details »
3 Adjusted total capital. See details »
4 2024 Calculation
Adjusted debt to capital = Adjusted total debt ÷ Adjusted total capital
= ÷ =
The analysis of the financial data over the five-year period reveals several noteworthy trends in the company's capital structure and debt management.
- Total Debt
- The total debt decreased consistently each year, starting at US$18,747 million at the end of 2020 and falling to US$14,125 million by the end of 2024. This steady reduction indicates a strategic effort to reduce leverage over the period.
- Total Capital
- Total capital showed minor fluctuations between 2020 and 2023, remaining within the range of approximately US$51,531 million to US$53,852 million, but then increased significantly to US$61,789 million in 2024. This increase in capital base might reflect growth initiatives, equity infusions, or retained earnings accumulation.
- Reported Debt to Capital Ratio
- This ratio declined steadily from 0.36 in 2020 to 0.23 in 2024, signaling an improving capital structure with progressively lower reliance on debt financing relative to total capital. It suggests enhanced financial stability and potentially lower financial risk.
- Adjusted Total Debt
- Similar to total debt, adjusted total debt also declined year-over-year from US$19,890 million in 2020 to US$15,275 million in 2024, reflecting consistent deleveraging when considering adjustments such as off-balance-sheet obligations or other factors.
- Adjusted Total Capital
- Adjusted total capital fluctuated slightly but remained broadly stable until a moderate increase to approximately US$55,321 million in 2024. This stability, combined with moderated growth, points to a balanced approach to capital base management.
- Adjusted Debt to Capital Ratio
- The adjusted debt to capital ratio decreased steadily from 0.37 in 2020 to 0.28 in 2024. Although slightly higher than the reported ratio, this trend likewise confirms a gradual reduction in leverage and improved capital structure quality over the period.
Overall, the data indicates a clear pattern of deleveraging and strengthening of capital base between 2020 and 2024. The company has managed to reduce both its reported and adjusted debt levels consistently while maintaining or increasing capital, resulting in a declining debt-to-capital ratio. This suggests enhanced financial flexibility and potentially improved creditworthiness in the analyzed timeframe.
Adjusted Financial Leverage
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
1 2024 Calculation
Financial leverage = Total assets ÷ Total Abbott shareholders’ investment
= ÷ =
2 Adjusted total assets. See details »
3 Adjusted total shareholders’ investment. See details »
4 2024 Calculation
Adjusted financial leverage = Adjusted total assets ÷ Adjusted total shareholders’ investment
= ÷ =
- Total Assets
- The total assets exhibited a modest fluctuation over the period. Beginning at 72,548 million US dollars at the end of 2020, the asset base rose to 75,196 million in 2021, then slightly declined to 74,438 million in 2022 and further decreased to 73,214 million in 2023. A notable increase occurred in 2024, with total assets reaching 81,414 million, marking the highest value in the five-year span.
- Total Abbott Shareholders’ Investment
- This figure displayed steady growth throughout the years. Starting from 32,784 million US dollars in 2020, it increased progressively each year to reach 47,664 million by the end of 2024. This consistent upward trend indicates strengthening equity positions and possibly increased retained earnings or additional capital influx.
- Reported Financial Leverage
- There was a clear decline in reported financial leverage ratios over the period. The ratio decreased from 2.21 in 2020 to 1.71 in 2024. This suggests a gradual reduction in the reliance on debt financing relative to equity, which could imply a more conservative capital structure or improved balance sheet strength.
- Adjusted Total Assets
- Adjusted total assets mirrored the trend in total assets but at slightly lower values. Beginning at 71,673 million in 2020, the figure rose to 74,303 million in 2021, then decreased marginally to 73,656 million in 2022 and 72,473 million in 2023. Unlike total assets, adjusted assets showed a small decline in 2024 to 73,038 million, indicating adjustments that temper the asset base growth seen in the reported measures.
- Adjusted Total Shareholders’ Investment
- This metric exhibited consistent growth year-over-year, advancing from 33,604 million in 2020 to 40,046 million in 2024. Although the adjusted equity values are lower than the reported values, the steady increase signals solid underlying improvements in shareholder value under adjusted accounting parameters.
- Adjusted Financial Leverage
- The adjusted financial leverage ratio also showed a declining trend, moving from 2.13 in 2020 down to 1.82 in 2024. While this decrease is not as pronounced as in the reported leverage, it similarly indicates a move toward reduced debt dependence relative to equity once adjustments are considered.
Adjusted Net Profit Margin
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
1 2024 Calculation
Net profit margin = 100 × Net earnings ÷ Net sales
= 100 × ÷ =
2 Adjusted net earnings. See details »
3 2024 Calculation
Adjusted net profit margin = 100 × Adjusted net earnings ÷ Net sales
= 100 × ÷ =
The financial data indicate varying trends in net earnings and sales over the five-year period ending in 2024. Net earnings experienced substantial growth overall, with a significant increase from 4,495 million US dollars in 2020 to 13,402 million US dollars in 2024, although there was a decline observed in 2023 compared to 2021 and 2022.
Net sales show a fluctuating pattern, rising from 34,608 million US dollars in 2020 to a peak of 43,653 million US dollars in 2022, followed by a decrease to 40,109 million US dollars in 2023, and a moderate recovery to 41,950 million US dollars in 2024. This suggests some variability in revenue generation during this timeframe.
The reported net profit margin follows a similar trajectory to net earnings, starting at 12.99% in 2020 and peaking at 31.95% in 2024, despite a dip between 2021 and 2023. The margin decline during the 2021-2023 period may reflect temporary challenges or increased costs, while the sharp rise in 2024 points to a notable improvement in profitability that exceeds earlier years substantially.
Adjusted net earnings also display growth from 3,933 million US dollars in 2020 to 5,331 million US dollars in 2024, with a peak in 2021 at 7,173 million US dollars. This measure demonstrates a more conservative view of profitability, excluding certain items, and reveals a decline after 2021, remaining relatively stable from 2023 to 2024.
The adjusted net profit margin mirrors the adjusted net earnings trend, increasing to 16.65% in 2021 but then decreasing consistently to 12.71% in 2024. This downward trend in adjusted profitability margins contrasts with the rise in reported net profit margin during 2024, indicating that earnings adjustments might have influenced the metrics differently.
- Summary of trends
- Net earnings and reported net profit margin both experienced growth with a large jump in 2024, despite prior volatility.
- Net sales peaked in 2022 before contracting and partially recovering.
- Adjusted net earnings and adjusted profit margins peaked in 2021 and subsequently declined or stabilized, showing more conservative profitability estimates.
- The divergence between reported and adjusted metrics in 2024 suggests extraordinary items or accounting adjustments contributed to the spike in reported profit margin and net earnings.
Adjusted Return on Equity (ROE)
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
1 2024 Calculation
ROE = 100 × Net earnings ÷ Total Abbott shareholders’ investment
= 100 × ÷ =
2 Adjusted net earnings. See details »
3 Adjusted total shareholders’ investment. See details »
4 2024 Calculation
Adjusted ROE = 100 × Adjusted net earnings ÷ Adjusted total shareholders’ investment
= 100 × ÷ =
The financial data reveals diverse trends in profitability, shareholder equity, and returns over the analyzed periods.
- Net Earnings
- The net earnings exhibit fluctuations over the five-year span. Beginning at 4,495 million US dollars in 2020, there was a notable rise to 7,071 million in 2021, followed by a slight decrease to 6,933 million in 2022. A more pronounced decline to 5,723 million occurred in 2023, before a substantial increase to 13,402 million in 2024. This pattern indicates a period of volatility with a strong recovery in the final year.
- Total Abbott Shareholders’ Investment
- Total shareholders’ investment steadily increased throughout the period, starting at 32,784 million US dollars in 2020 and rising consistently to reach 47,664 million by 2024. This steady growth suggests ongoing capital infusion or retained earnings contributing to equity expansion.
- Reported Return on Equity (ROE)
- The reported ROE shows an upward trend with some variability. It increased from 13.71% in 2020 to a peak of 19.75% in 2021, slightly declined in subsequent years to 14.83% in 2023, before sharply rising to 28.12% in 2024. The spike in 2024 aligns with the significant surge in net earnings that year, indicating enhanced profitability relative to equity.
- Adjusted Net Earnings
- Adjusted net earnings also demonstrate instability but with less pronounced extremes compared to reported net earnings. After rising from 3,933 million in 2020 to a peak of 7,173 million in 2021, they declined gradually over the next three years, ending at 5,331 million in 2024. This suggests adjustments may have mitigated some of the large fluctuations in reported figures.
- Adjusted Total Shareholders’ Investment
- This metric increased steadily from 33,604 million in 2020 to 40,046 million in 2024, though the growth rate appears more moderate compared to unadjusted shareholders’ investment. This steadier increase implies a more conservative reflection of equity changes after adjustment.
- Adjusted Return on Equity (ROE)
- The adjusted ROE shows an increase from 11.7% in 2020 to 19.59% in 2021, followed by a gradual decline over the subsequent years to 13.31% in 2024. Unlike the reported ROE, the adjusted ROE does not exhibit a sharp increase in the final year, reflecting a more consistent but lower profitability relative to adjusted equity.
Overall, the data portrays considerable fluctuations in earnings and returns, with reported figures suggesting higher volatility and pronounced peaks, particularly in 2024. Total shareholders’ investment has shown steady growth under both reported and adjusted measurements, indicating a solid foundation of equity. The divergence between reported and adjusted ROE in the final year points to the influence of accounting adjustments on the assessment of profitability trends.
Adjusted Return on Assets (ROA)
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
1 2024 Calculation
ROA = 100 × Net earnings ÷ Total assets
= 100 × ÷ =
2 Adjusted net earnings. See details »
3 Adjusted total assets. See details »
4 2024 Calculation
Adjusted ROA = 100 × Adjusted net earnings ÷ Adjusted total assets
= 100 × ÷ =
The analysis of the annual financial data over the five-year period reveals several notable trends in earnings, assets, and returns on assets (ROA), both reported and adjusted.
- Net Earnings
- Net earnings demonstrated strong growth overall, rising from 4,495 million US dollars in 2020 to a peak of 7,071 million in 2021. After a slight decline to 6,933 million in 2022 and further reduction to 5,723 million in 2023, net earnings then surged significantly to 13,402 million in 2024. This final figure marks a substantial increase, nearly doubling the previous year's earnings.
- Total Assets
- Total assets showed moderate fluctuations across the period. Beginning at 72,548 million US dollars at the end of 2020, assets grew marginally to 75,196 million in 2021. They then experienced a slight decline in the following two years, reaching 73,214 million in 2023. However, a notable increase occurred in 2024, with assets climbing to 81,414 million, the highest level in the reviewed timeframe.
- Reported ROA (Return on Assets)
- Reported ROA trends followed earnings and asset patterns with initial improvement from 6.2% in 2020 to 9.4% in 2021. This figure remained relatively stable in 2022 at 9.31% but decreased to 7.82% in 2023. A significant recovery occurred in 2024 when reported ROA more than doubled to 16.46%, indicating improved efficiency in generating earnings from assets.
- Adjusted Net Earnings
- Adjusted net earnings displayed a pattern somewhat similar to the reported figures but with less volatility. Starting at 3,933 million US dollars in 2020, adjusted earnings peaked at 7,173 million in 2021. Subsequent declines to 6,718 million in 2022 and 5,270 million in 2023 were noted, followed by a marginal increase to 5,331 million in 2024. These figures suggest a relatively stabilised adjusted earnings performance compared to the reported net earnings.
- Adjusted Total Assets
- Adjusted total assets tracked closely with reported assets, starting at 71,673 million in 2020, increasing to 74,303 million in 2021, and gradually decreasing each year to 72,473 million in 2023. Unlike reported assets, adjusted assets only slightly increased to 73,038 million in 2024, indicating a more conservative asset valuation or adjustment methodology.
- Adjusted ROA
- Adjusted ROA remained relatively consistent throughout the period, starting at 5.49% in 2020 and increasing to 9.65% in 2021. It experienced a moderate decline to 9.12% in 2022 and further dropped to 7.27% in 2023 before stabilising slightly at 7.3% in 2024. The adjusted ROA did not replicate the dramatic increase seen in the reported ROA for 2024, reflecting a steadier return perspective after adjustments.
In summary, the company demonstrated strong earnings growth and improved asset management efficiency as indicated by the reported ROA in 2024. However, the adjusted earnings and returns suggest more moderate performance gains, highlighting the potential impact of accounting adjustments on financial results. Asset levels remained largely stable with a notable increase in 2024, supporting the rise in net earnings and reported profitability during that year.